Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Explore Tonums research and packaging guidance to make safer choices
The medication slows gastric emptying by activating GLP-1 receptors throughout the gastrointestinal tract, causing delayed stomach-to-intestine transit
While existing GLP-1 medications have shown greater weight loss than Eli Lillys oral medication, the oral option targets both weight loss and type 2 diabetes in patients
G-actin sequestration driving actin polymerization, ILK-PI3K-Akt cell survival signaling, VEGF-mediated angiogenesis, MMP-driven ECM remodeling, NF-B anti-inflammatory modulation Beginner protocol mg / Woche Advanced protocol 2.5-5 mg twice weekly, subcutaneously Note: The dosages listed correspond to typical ranges from published research literature
If additional glycemic control is needed, the dose can be further increased to 1 mg and 2 mg once weekly
Flatten the blood sugar
